Back

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 6 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Victor Donoso

University Hospital La Fe, Valencia (Spain)

4 More presentations in this session

Presentation thumbnail
Nation-wide use of guideline-directed medical therapies in heart failure across the ejection fraction range: The HECMOS study
Doctor I. Leontsinis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
SGLT2i treatment at the beginning of real time exposure in a HFrEF population
Associate Professor V. Vintila (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
The daily challenges to patients posed by diuretic therapy; what they are and what do patients do?
Doctor G. Bruno (Limerick, IE)
Abstract Slides Video
Presentation thumbnail
CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and cardiorenal syndrome
Mr G. Nunez Marin (Valencia, ES)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy 6

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Clinical predictors of left ventricular ejection fraction recovery in patients with ischemic etiology heart failure: a real-world study.
thumbnail
Congress Presentation
Comprehensive characterization of patients with heart failure and recovered ejection fraction: insights from a real-world population from a regional hospital in Portugal
thumbnail
Congress Presentation
Factors influencing the recovery of ejection fraction in heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources